Treatment for T-ALL generally involves a multi-phase chemotherapy regimen, which may include induction, consolidation, and maintenance phases. Additional treatments may include radiation therapy, targeted therapy, and bone marrow transplants. Newer treatments, such as CAR-T cell therapy, have shown promise in clinical trials and offer hope for more effective management of the disease.
